Jpmorgan Chase & CO Immuno Precise Antibodies Ltd. Call Options Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
26Shares Held
3.93MCall Options Held
27.2KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.76MShares$3.01 Million0.03% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA703KShares$766,2700.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.6KShares$98,7340.0% of portfolio
-
Virtu Financial LLC New York, NY57.8KShares$63,0530.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$44,9080.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $27.1M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...